[1]
|
GBD 2019 Diseases and Injuries Collaborators (2020) Global Burden of 369 Diseases and Injuries in 204 Countries and Territories, 1990-2019: A Systematic Analysis for the Global Burden of Disease Study 2019. Lancet, 396, 1204-1222. https://doi.org/10.1016/S0140-6736(20)30925-9
|
[2]
|
Krishnamurthi, R.V., Ikeda, T. and Feigin, V.L. (2020) Global, Regional and Country-Specific Burden of Ischaemic Stroke, Intracerebral Haemorrhage and Subarachnoid Haemorrhage: A Systematic Analysis of the Global Burden of Disease Study 2017. Neuroepidemiology, 54, 171-179. https://doi.org/10.1159/000506396
|
[3]
|
Kilic, U., Caglayan, A.B., Beker, M.C., Gunal, M.Y., Caglayan, B., Yalcin, E., et al. (2017) Particular Phosphorylation of PI3K/Akt on Thr308 via PDK-1 and PTEN Mediates Melatonin’s Neuroprotective Activity after Focal Cerebral Ischemia in Mice. Redox Biology, 12, 657-665. https://doi.org/10.1016/j.redox.2017.04.006
|
[4]
|
Yawoot, N., Govitrapong, P., Tocharus, C. and Tocharus, J. (2020) Ischemic Stroke, Obesity, and the Anti-Inflammatory Role of Melatonin. BioFactors (Oxford, England), 47, 41-58. https://doi.org/10.1002/biof.1690
|
[5]
|
Kılıç, E., Çağlayan, B. and Caglar Beker, M. (2020) Physiological and Pharmacological Roles of Melatonin in the Pathophysiological Components of Cellular Injury after Ischemic Stroke. Turkish Journal of Medical Sciences, 50, 1655-1664. https://doi.org/10.3906/sag-2008-32
|
[6]
|
Zhao, Y., Xiao, M., He, W., Cai, Z., Tang, Z. and Tian, F. (2015) Minocycline Upregulates Cyclic AMP Response Element Binding Protein and Brain-Derived Neurotrophic Factor in the Hippocampus of Cerebral Ischemia Rats and Improves Behavioral Deficits. Neuropsychiatric Disease and Treatment, 11, 507-516.
https://doi.org/10.2147/NDT.S73836
|
[7]
|
Sadanandan, N., Cozene, B., Cho, J., Park, Y.J., Saft, M., Gonzales-Portillo, B., et al. (2020) Melatonin—A Potent Therapeutic for Stroke and Stroke-Related Dementia. Antioxidants, 9, Article No. 672.
https://doi.org/10.3390/antiox9080672
|
[8]
|
Al Dera, H., Alassiri, M., Eleawa, S.M., AlKhateeb, M.A., Hussein, A.M., Dallak, M., et al. (2019) Melatonin Improves Memory Deficits in Rats with Cerebral Hypoperfusion, Possibly, Through Decreasing the Expression of Small-Conductance Ca2+-Activated K+ Channels. Neurochemical Research, 44, 1851-1868.
https://doi.org/10.1007/s11064-019-02820-6
|
[9]
|
Bin-Jaliah, I. and Sakr, H. (2018) Melatonin Ameliorates Brain Oxidative Stress and Upregulates Senescence Marker Protein-30 and Osteopontin in a Rat Model of Vascular Dementia. Physiology International, 105, 38-52.
https://doi.org/10.1556/2060.105.2018.1.1
|
[10]
|
De Butte, M. and Gieseking, B. (2020) Efficacy of a Low-Dose Melatonin Pretreatment in Protecting against the Neurobehavioral Consequences of Chronic Hypoperfusion in Middle-Aged Female Rats. Behavioural Brain Research, 377, Article ID: 112257. https://doi.org/10.1016/j.bbr.2019.112257
|
[11]
|
Rancan, L., Paredes, S.D., García, C., González, P., Rodríguez-Bobada, C., Calvo-Soto, M., et al. (2018) Comparison of the Effect of Melatonin Treatment Before and after Brain Ischemic Injury in the Inflammatory and Apoptotic Response in Aged Rats. International Journal of Molecular Sciences, 19, Article No. 2097.
https://doi.org/10.3390/ijms19072097
|
[12]
|
Azedi, F., Mehrpour, M., Talebi, S., Zendedel, A., Kazemnejad, S., Mousavizadeh, K., et al. (2019) Melatonin Regulates Neuroinflammation Ischemic Stroke Damage through Interactions with Microglia in Reperfusion Phase. Brain Research, 1723, Article ID: 146401. https://doi.org/10.1016/j.brainres.2019.146401
|
[13]
|
Muhammad, T., Ali, T., Ikram, M., Khan, A., Alam, S.I. and Kim, M.O. (2019) Melatonin Rescue Oxidative Stress-Mediated Neuroinflammation/Neurodegeneration and Memory Impairment in Scopolamine-Induced Amnesia Mice Model. Journal of Neuroimmune Pharmacology, 14, 278-294. https://doi.org/10.1007/s11481-018-9824-3
|
[14]
|
Zhang, E. and Liao, P. (2020) Brain-Derived Neurotrophic Factor and Post-Stroke Depression. Journal of Neuroscience Research, 98, 537-548. https://doi.org/10.1002/jnr.24510
|
[15]
|
Wang, X.M., Zhang, Y.G., Li, A.L., Long, Z.H., Wang, D., Li, X.X., et al. (2016) Expressions of Serum Inflammatory Cytokines and Their Relationship with Cerebral Edema in Patients with Acute Basal Ganglia Hemorrhage. European Review for Medical and Pharmacological Sciences, 20, 2868-2871.
|
[16]
|
Eyileten, C., Sharif, L., Wicik, Z., Jakubik, D., Jarosz-Popek, J., Soplinska, A., et al. (2021) The Relation of the Brain-Derived Neurotrophic Factor with MicroRNAs in Neurodegenerative Diseases and Ischemic Stroke. Molecular Neurobiology, 58, 329-347. https://doi.org/10.1007/s12035-020-02101-2
|
[17]
|
Popova, N.K., Ilchibaeva, T.V. and Naumenko, V.S. (2017) Neurotrophic Factors (BDNF and GDNF) and the Serotonergic System of the Brain. Biochemistry (Moscow), 82, 308-317. https://doi.org/10.1134/S0006297917030099
|
[18]
|
Liu, W., Wang, X., O’Connor, M., Wang, G. and Han, F. (2020) Brain-Derived Neurotrophic Factor and Its Potential Therapeutic Role in Stroke Comorbidities. Neural Plasticity, 2020, Article ID: 1969482.
https://doi.org/10.1155/2020/1969482
|
[19]
|
Zhang, X., Zhou, Y., Li, H., Wang, R., Yang, D., Li, B., et al. (2018) Intravenous Administration of DPSCs and BDNF Improves Neurological Performance in Rats with Focal Cerebral Ischemia. International Journal of Molecular Medicine, 41, 3185-3194. https://doi.org/10.3892/ijmm.2018.3517
|
[20]
|
Ramos-Cejudo, J., Gutiérrez-Fernández, M., Otero-Ortega, L., Rodríguez-Frutos, B., Fuentes, B., Vallejo-Cremades, M.T., et al. (2015) Brain-Derived Neurotrophic Factor Administration Mediated Oligodendrocyte Differentiation and Myelin Formation in Subcortical Ischemic Stroke. Stroke, 46, 221-228.
https://doi.org/10.1161/STROKEAHA.114.006692
|
[21]
|
Kalinichenko, S.G., Matveeva, N.Y. and Korobtsov, A.V. (2020) Brain-Derived Neurotrophic Factor (BDNF) As a Regulator of Apoptosis under Conditions of Focal Experimental Stroke. Bulletin of Experimental Biology and Medicine, 169, 701-706. https://doi.org/10.1007/s10517-020-04959-7
|
[22]
|
Ishii, T., Warabi, E. and Mann, G.E. (2019) Circadian Control of BDNF-Mediated Nrf2 Activation in Astrocytes Protects Dopaminergic Neurons from Ferroptosis. Free Radical Biology & Medicine, 133, 169-178.
https://doi.org/10.1016/j.freeradbiomed.2018.09.002
|
[23]
|
Zhao, H., Alam, A., San, C.Y., Eguchi, S., Chen, Q., Lian, Q., et al. (2017) Molecular Mechanisms of Brain-Derived Neurotrophic Factor in Neuro-Protection: Recent Developments. Brain Research, 1665, 1-21.
https://doi.org/10.1016/j.brainres.2017.03.029
|
[24]
|
Han, F., Guan, X., Guo, W. and Lu, B. (2019) Therapeutic Potential of a TrkB Agonistic Antibody for Ischemic Brain Injury. Neurobiology of Disease, 127, 570-581. https://doi.org/10.1016/j.nbd.2019.04.009
|
[25]
|
Miranda, M., Morici, J.F., Zanoni, M.B. and Bekinschtein, P. (2019) Brain-Derived Neurotrophic Factor: A Key Molecule for Memory in the Healthy and the Pathological Brain. Frontiers in Cellular Neuroscience, 13, Article No. 363.
https://doi.org/10.3389/fncel.2019.00363
|
[26]
|
Menzie-Suderam, J.M., Mohammad-Gharibani, P., Modi, J., Ma, Z., Tao, R., Prentice, H., et al. (2018) Granulocyte-Colony Stimulating Factor Protects against Endoplasmic Reticulum Stress in an Experimental Model of Stroke. Brain Research, 1682, 1-13. https://doi.org/10.1016/j.brainres.2017.12.022
|
[27]
|
Wu, M.Y., Yiang, G.T., Liao, W.T., Tsai, A.P., Cheng, Y.L., Cheng, P.W., et al. (2018) Current Mechanistic Concepts in Ischemia and Reperfusion Injury. Cellular Physiology and Biochemistry, 46, 1650-1667.
https://doi.org/10.1159/000489241
|
[28]
|
Modi, J., Menzie-Suderam, J., Xu, H., Trujillo, P., Medley, K., Marshall, M.L., et al. (2020) Mode of Action of Granulocyte-Colony Stimulating Factor (G-CSF) as a Novel Therapy for Stroke in a Mouse Model. Journal of Biomedical Science, 27, Article No. 19. https://doi.org/10.1186/s12929-019-0597-7
|
[29]
|
Huang, X., Liu, Y., Bai, S., Peng, L., Zhang, B. and Lu, H. (2017) Granulocyte Colony Stimulating Factor Therapy for Stroke: A Pairwise Meta-Analysis of Randomized Controlled Trial. PLoS ONE, 12, e175774.
https://doi.org/10.1371/journal.pone.0175774
|
[30]
|
Dumbuya, J.S., Chen, L., Shu, S.Y., Ma, L., Luo, W., Li, F., et al. (2020) G-CSF Attenuates Neuroinflammation and Neuronal Apoptosis via the mTOR/p70SK6 Signaling Pathway in Neonatal Hypoxia-Ischemia Rat Model. Brain Research, 1739, Article ID: 146817. https://doi.org/10.1016/j.brainres.2020.146817
|
[31]
|
Menzie-Suderam, J.M., Modi, J., Xu, H., Bent, A., Trujillo, P., Medley, K., et al. (2020) Granulocyte-Colony Stimulating Factor Gene Therapy as a Novel Therapeutics for Stroke in a Mouse Model. Journal of Biomedical Science, 27, Article No. 99. https://doi.org/10.1186/s12929-020-00692-5
|
[32]
|
Ping, S., Qiu, X., Gonzalez-Toledo, M.E., Liu, X. and Zhao, L.R. (2018) Stem Cell Factor in Combination with Granulocyte Colony-Stimulating Factor Reduces Cerebral Capillary Thrombosis in a Mouse Model of CADASIL. Cell Transplantation, 27, 637-647. https://doi.org/10.1177%2F0963689718766460
|
[33]
|
Wang, M.-L., Zhang, L.-X., Wei, J.-J., Li, L.-L., Zhong, W.-Z., Lin, X.-J., et al. (2020) Granulocyte Colony-Stimulating Factor and Stromal Cell-Derived Factor-1 Combination Therapy: A More Effective Treatment for Cerebral Ischemic Stroke. International Journal of Stroke, 15, 743-754. https://doi.org/10.1177%2F1747493019879666
|
[34]
|
Kabekkodu, S.P., Shukla, V., Varghese, V.K., D’Souza, J., Chakrabarty, S. and Satyamoorthy, K. (2018) Clustered miRNAs and Their Role in Biological Functions and Diseases. Biological Reviews, 93, 1955-1986.
https://doi.org/10.1111/brv.12428
|
[35]
|
Li, P., Stetler, R.A., Leak, R.K., Shi, Y., Li, Y., Yu, W., et al. (2018) Oxidative Stress and DNA Damage after Cerebral Ischemia: Potential Therapeutic Targets to Repair the Genome and Improve Stroke Recovery. Neuropharmacology, 134, 208-217. https://doi.org/10.1016/j.neuropharm.2017.11.011
|
[36]
|
Xi, T., Jin, F., Zhu, Y., Wang, J., Tang, L., Wang, Y., et al. (2017) MicroRNA-126-3p Attenuates Blood-Brain Barrier Disruption, Cerebral Edema and Neuronal Injury Following Intracerebral Hemorrhage by Regulating PIK3R2 and Akt. Biochemical and Biophysical Research Communications, 494, 144-151. https://doi.org/10.1016/j.bbrc.2017.10.064
|
[37]
|
Pan, J., Qu. M., Li, Y., Wang, L., Zhang, L., Wang, Y., et al. (2020) MicroRNA-126-3p/-5p Overexpression Attenuates Blood-Brain Barrier Disruption in a Mouse Model of Middle Cerebral Artery Occlusion. Stroke, 51, 619-627.
https://doi.org/10.1161/STROKEAHA.119.027531
|
[38]
|
Xie, K., Cai, Y., Yang, P., Du, F. and Wu, K. (2020) Upregulating MicroRNA-874-3p Inhibits CXCL12 Expression to Promote Angiogenesis and Suppress Inflammatory Response in Ischemic Stroke. American Journal of Physiology-Cell physiology, 319, C579-C588. https://doi.org/10.1152/ajpcell.00001.2020
|
[39]
|
Fan, J., Xu, W., Nan, S., Chang, M. and Zhang, Y. (2020) MicroRNA-384-5p Promotes Endothelial Progenitor Cell Proliferation and Angiogenesis in Cerebral Ischemic Stroke through the Delta-Likeligand 4-Mediated Notch Signaling Pathway. Cerebrovascular Diseases, 49, 39-54. https://doi.org/10.1159/000503950
|
[40]
|
Yan, Y., Song, X., Li, Z., Zhang, J., Ren, J., Wu, J., et al. (2017) Elevated Levels of Granzyme B Correlated with miR-874-3p Downregulation in Patients with Acute Myocardial Infarction. Biomarkers in Medicine, 11, 761-767.
https://doi.org/10.2217/bmm-2017-0144
|
[41]
|
Fu, C., Chen, S., Cai, N., Liu, Z., Wang, P. and Zhao, J. (2019) Potential Neuroprotective Effect of miR-451 against Cerebral Ischemia/Reperfusion Injury in Stroke Patients and a Mouse Model. World Neurosurgery, 130, e54-e61.
https://doi.org/10.1016/j.wneu.2019.05.194
|
[42]
|
Dong, R., Zhang, M., Hu, Q., Zheng, S., Soh, A., Zheng, Y., et al. (2018) Galectin-3 as a Novel Biomarker for Disease Diagnosis and a Target for Therapy (Review). International Journal of Molecular Medicine, 41, 599-614.
https://doi.org/10.3892/ijmm.2017.3311
|
[43]
|
Thomas, L. and Pasquini, L.A. (2018) Galectin-3-Mediated Glial Crosstalk Drives Oligodendrocyte Differentiation and (Re)myelination. Frontiers in Cellular Neuroscience, 12, Article No. 297. https://doi.org/10.3389/fncel.2018.00297
|
[44]
|
Kariya, Y., Oyama, M., Hashimoto, Y., Gu, J. and Kariya, Y. (2018) β4-Integrin/PI3K Signaling Promotes Tumor Progression through the Galectin-3—N-Glycan Complex. Molecular Cancer Research, 16, 1024-1034.
https://doi.org/10.1158/1541-7786.MCR-17-0365
|
[45]
|
Thomas, L. and Pasquini, L.A. (2019) Extracellular Galectin-3 Induces Accelerated Oligodendroglial Differentiation through Changes in Signaling Pathways and Cytoskeleton Dynamics. Molecular Neurobiology, 56, 336-349.
https://doi.org/10.1007/s12035-018-1089-6
|
[46]
|
Rahimian, R., Béland, L.C. and Kriz, J. (2018) Galectin-3: Mediator of Microglia Responses in Injured Brain. Drug Discovery Today, 23 375-381. https://doi.org/10.1016/j.drudis.2017.11.004
|
[47]
|
Burguillos, M.A., Svensson, M., Schulte, T., Boza-Serrano, A., Garcia-Quintanilla, A., Kavanagh, E., et al. (2015) Microglia-Secreted Galectin-3 Acts as a Toll-like Receptor 4 Ligand and Contributes to Microglial Activation. Cell Reports, 10, 1626-1638. https://doi.org/10.1016/j.celrep.2015.02.012
|
[48]
|
Winter, M.P., Wiesbauer, F., Alimohammadi, A., Blessberger, H., Pavo, N., Schillinger, M., et al. (2016) Soluble Galectin-3 Is Associated with Premature Myocardial Infarction. European Journal of Clinical Investigation, 46, 386-391.
https://doi.org/10.1111/eci.12605
|
[49]
|
Wang, A., Zhong, C., Zhu, Z., Xu, T., Peng, Y., Xu, T., et al. (2018) Serum Galectin-3 and Poor Outcomes among Patients with Acute Ischemic Stroke. Stroke, 49, 211-214. https://doi.org/10.1161/STROKEAHA.117.019084
|
[50]
|
Gao, Z., Liu, Z., Wang, R., Zheng, Y., Li, H. and Yang, L. (2020) Galectin-3 Is a Potential Mediator for Atherosclerosis. Journal of Immunology Research, 2020, Article ID: 5284728. https://doi.org/10.1155/2020/5284728
|
[51]
|
Subhash, V.V., Ling, S.S.M. and Ho, B. (2016) Extracellular Galectin-3 Counteracts Adhesion and Exhibits Chemoattraction in Helicobacter Pylori-Infected Gastric Cancer Cells. Microbiology (Reading, England), 162, 1360-1366.
https://doi.org/10.1099/mic.0.000322
|
[52]
|
Wright, R.D., Souza, P.R., Flak, M.B., Thedchanamoorthy, P., Norling, L.V. and Cooper, D. (2017) Galectin-3-Null Mice Display Defective Neutrophil Clearance during Acute Inflammation. Journal of Leukocyte Biology, 101, 717-726.
https://doi.org/10.1189/jlb.3A0116-026RR
|
[53]
|
Schoultz, I., Verma, D., Halfvarsson, J., Törkvist, L., Fredrikson, M., Sjöqvist, U., et al. (2020) Combined Polymorphisms in Genes Encoding the Inflammasome Components NLRP3 and CARD8 Confer Risk of Ischemic Stroke in Men. Journal of Stroke and Cerebrovascular Diseases, 29, Article ID: 104874.
https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.104874
|
[54]
|
Lammerding, L, Slowik, A., Johann, S., Beyer, C. and Zendedel, A. (2016) Poststroke Inflammasome Expression and Regulation in the Peri-Infarct Area by Gonadal Steroids after Transient Focal Ischemia in the Rat Brain. Neuroendocrinology, 103, 460-475. https://doi.org/10.1159/000439435
|
[55]
|
Minutoli, L., Puzzolo, D., Rinaldi, M., Irrera, N., Marini, H., Arcoraci, V., et al. (2016) ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury. Oxidative Medicine and Cellular Longevity, 2016, Article ID: 2183026. https://doi.org/10.1155/2016/2183026
|
[56]
|
Kelley, N., Jeltema, D., Duan, Y. and He, Y. (2019) The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation. International Journal of Molecular Sciences, 20, Article No. 3328.
https://doi.org/10.3390/ijms20133328
|
[57]
|
Wang, H., Zhong, D., Chen, H., Jin, J., Liu, Q. and Li, G. (2019) NLRP3 Inflammasome Activates Interleukin-23/Interleukin-17 Axis during Ischaemia-Reperfusion Injury in Cerebral Ischaemia in Mice. Life sciences, 227, 101-113. https://doi.org/10.1016/j.lfs.2019.04.031
|
[58]
|
Feng, Y.-S., Tan, Z.-X., Wang, M.-M., Xing, Y., Dong, F. and Zhang, F. (2020) Inhibition of NLRP3 Inflammasome: A Prospective Target for the Treatment of Ischemic Stroke. Frontiers in Cellular Neuroscience, 14, Article No. 155.
https://doi.org/10.3389/fncel.2020.00155
|
[59]
|
Zhang, S., Jiang, L., Che, F., Lu, Y., Xie, Z. and Wang, H. (2017) Arctigenin Attenuates Ischemic Stroke via SIRT1-Dependent Inhibition of NLRP3 Inflammasome. Biochemical and Biophysical Research Communications, 493, 821-826. https://doi.org/10.1016/j.bbrc.2017.08.062
|
[60]
|
He, X.F., Zeng, Y.X., Li, G., Feng, Y.K., Wu, C., Liang, F.Y., et al. (2020) Extracellular ASC Exacerbated the Recurrent Ischemic Stroke in an NLRP3-Dependent Manner. Journal of Cerebral Blood Flow and Metabolism, 40, 1048-1060.
https://doi.org/10.1177%2F0271678X19856226
|